PPI-461

· Presidio Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PPI-461, covering 2012-02-03 to 2012-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1b Study of PPI-461 in Patients With HCV Genotype 1 [Phase 1]